Profitability
Weight: 20%
F
0
- 5yr Avg ROIC -24.1%
- Operating Margin Trend -1783.71 pp/yr
RVMD
Revolution Medicines, Inc.
AlphaQuality composite grade, weighted for stable earnings power businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.
Grade overrides the 16.1 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -31.9%
- 5yr Share-Count CAGR 27.1%
Growth Quality
Weight: 15%
F
11
- 5yr Revenue CAGR -37.2%
- 5yr EPS CAGR 0.0%
- Revenue-Growth Years (5) 1/5
Cash Generation
Weight: 15%
F
0
- 5yr FCF Margin -1427.3%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 20%
F
25
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) -45.69x
- Altman Z-Score 22.86
Stability
Weight: 15%
B-
63
- EPS Volatility (σ/μ) 0.00
- Piotroski F-Score 1
- Negative-Revenue Years (5) 2/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.4 of 4 gurus held; 1 new buy; 1 added; 2 trimmed.
- Holders
- 4 +1
- Avg Δ position
- -62.4%
- New buys
- 1
- Full exits
- 0
- Druckenmiller new
- Wood decreased -99%
- Cooperman decreased -98%